Diversified Trust Co Takes $57,000 Position in Aveanna Healthcare Holdings Inc. $AVAH

Diversified Trust Co acquired a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHFree Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 10,884 shares of the company’s stock, valued at approximately $57,000.

A number of other large investors have also recently bought and sold shares of AVAH. Ameriprise Financial Inc. bought a new stake in Aveanna Healthcare in the fourth quarter valued at $248,000. BNP Paribas Financial Markets bought a new stake in shares of Aveanna Healthcare in the 4th quarter worth about $35,000. Bank of America Corp DE grew its holdings in shares of Aveanna Healthcare by 43.4% in the 4th quarter. Bank of America Corp DE now owns 50,040 shares of the company’s stock worth $229,000 after purchasing an additional 15,140 shares during the last quarter. Deutsche Bank AG grew its stake in Aveanna Healthcare by 32.1% during the fourth quarter. Deutsche Bank AG now owns 34,564 shares of the company’s stock worth $158,000 after buying an additional 8,396 shares during the last quarter. Finally, Millennium Management LLC grew its stake in Aveanna Healthcare by 105.0% during the fourth quarter. Millennium Management LLC now owns 400,374 shares of the company’s stock worth $1,830,000 after buying an additional 205,023 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on AVAH. Jefferies Financial Group upgraded Aveanna Healthcare from a “hold” rating to a “buy” rating and decreased their price target for the stock from $6.25 to $6.00 in a research report on Monday, July 21st. Raymond James Financial upgraded Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 target price on the stock in a report on Monday, August 11th. UBS Group raised shares of Aveanna Healthcare from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $6.75 to $8.00 in a report on Tuesday, August 19th. Wall Street Zen raised shares of Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 9th. Finally, Truist Financial decreased their price target on shares of Aveanna Healthcare from $6.00 to $5.00 and set a “hold” rating on the stock in a research note on Wednesday, July 16th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $7.92.

Get Our Latest Stock Analysis on AVAH

Aveanna Healthcare Trading Down 0.4%

Shares of NASDAQ AVAH opened at $8.36 on Thursday. The firm has a market capitalization of $1.75 billion, a PE ratio of 104.50 and a beta of 2.04. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.67 and a 1 year high of $8.68. The firm’s 50-day moving average is $6.61 and its 200-day moving average is $5.54.

Aveanna Healthcare Company Profile

(Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Recommended Stories

Institutional Ownership by Quarter for Aveanna Healthcare (NASDAQ:AVAH)

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.